Our Featured Experts

Brian I. Rini, MD
Oliver Sartor, MD
Dr. Sartor on the Science of Sipuleucel-T for Prostate Cancer
Oliver Sartor, MD, a medical oncologist at the Tulane University School of Medicine, discusses the science behind the results of a study investigating sipuleucel-T (Provenge) for patients with castration-resistant prostate cancer (CRPC).
Oncology Specialists
Publication Bottom Border
Border Publication